Posted on

cbd oil nhs

CBD Queen exerts the greatest effort into creating leading cannabis products, and that’s why their customers remain loyal.

All indications point to the fact that UK residents trust CBD for managing numerous health problems.

Lab Reports

(Click here if you want to learn how CBD oil works or here if you want to read about if can you drive on CBD oil in the UK).

This is a major win in the struggle to make CBD a health supplement.

This drug is used as treatment against epilepsy, a neurological disorder characterized by seizures and abnormal behaviors.

This page from Great Ormond Street Hospital (GOSH) describes the approach we take to cannabinoid (cannabis) oil. It has been compiled by the Palliative Care Team, Safeguarding, Social Work and Complex Epilepsy teams at GOSH.Note: This information does not apply to Epidiolex® a prescribed cannabinoid medication for complex epilepsy.

As clinicians, we value the open and honest discussion with parents and carers about the use of cannabinoid oils and actively encourage all parents and carers discuss this difficult subject with us. Despite the extreme importance of informing of families informing staff of administration of cannabinoid oil, we are currently in the difficult position of not being able to support administration.

What is cannabidiol and what are cannabinoid oils?

GOSH will continue to work closely with the government and national bodies to ensure that we are always up to date with research evidence, national policy and licensing regulation.

In the UK, cannabis derived products containing more than 1mg of THC are considered illegal unless it holds authorisation from the Medicines and Healthcare Products Regulatory Authority (MHRA). MHRA authorisation for medicinal use of a chemical or drug requires the drug to demonstrate safety and benefit in well designed, randomised studies usually against placebo (dummy therapy) or current gold standard therapy, as well meeting stringent pharmaceutical quality standards.

Known side-effects of cannabinoids determined from clinical trials include sedation, appetite suppression, diarrhoea, dizziness and abnormal liver function.